Krystal Biotech focuses on US genetic medicines, while IREN's growth surpasses the US market average and Anthony Lewis was appointed CCO.
2 reports, 0 independent
Updated Jul 7
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Krystal Biotech focuses on US genetic medicines, while IREN's growth surpasses the US market average and Anthony Lewis was appointed CCO.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Krystal Biotech, Inc.
biotechnology company
Nothing else this week.
-
IREN
Australian data center company
-
Frontline
shipping company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet